MedPath

Incidence of transient neurological symptoms following spinal anesthesia with hyperbaric mepivacaine 4 % and the use of 2 ml cerebrospinal fluid for barbotage

Conditions
patients operated in spinal anesthesia
Registration Number
DRKS00031420
Lead Sponsor
Evangelisches Krankenhaus Göttingen Weende
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
198
Inclusion Criteria

scheduled operation in spinal anesthesia

Exclusion Criteria

age < 18 years
neurological disease
procedure performed as same day surgery

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of transient neurological symptoms within 4 days after spinal anesthesia compared between the groups treated with mepivacaine 4 % hyperbaric and bupivacaine 0,5 % isobaric. Ward rounds were performed on postoperative days 1 and 4. If Patients were discharged before day 4 an interview via phone was carried out.
Secondary Outcome Measures
NameTimeMethod
incidence of post-punctural headache<br>incidence of infections at the puncture site
© Copyright 2025. All Rights Reserved by MedPath